Oura's CEO Tom Hale emphasized the role of AI development in their strategy, stating, 'We know that Oura has the potential to change lives at scale, and we're excited to continue leading the market in innovation while pursuing opportunities that extend beyond the ring.'
Notably, the partnership with Dexcom allows Oura to assist users in monitoring blood sugar levels, highlighting a significant expansion of functionality for its smart rings.
The company's impressive growth is underscored by the fact that Oura has sold over 2.5 million rings, with its member base and revenue having more than doubled in the last year.
Oura’s Series D funding round, which raised $200 million, was supported by notable investors like Fidelity Management and Dexcom, which invested $75 million.
Collection
[
|
...
]